Kaleido Biosciences   Report issue

For profit Phase 2
Founded: Bedford MA United States (2015)
Status: Defunct (2022)

Organization Overview

First Clinical Trial
2015
NCT02628652
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kaleido Biosciences | Kaleido Boisciences

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 2)

Urea Cycle Disorders, Inborn (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 11
  • # of Trial APIs: 9